A detailed history of Putnam Investments LLC transactions in Insmed Inc stock. As of the latest transaction made, Putnam Investments LLC holds 387,674 shares of INSM stock, worth $27.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
387,674
Holding current value
$27.2 Million
% of portfolio
0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $9.08 Million - $12.3 Million
387,674 New
387,674 $12 Million
Q1 2023

May 22, 2023

SELL
$16.26 - $21.73 $1.32 Million - $1.76 Million
-81,213 Reduced 31.92%
173,251 $2.95 Million
Q4 2022

Feb 14, 2023

BUY
$16.98 - $23.15 $62,520 - $85,238
3,682 Added 1.47%
254,464 $5.08 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $643,772 - $869,770
30,832 Added 14.02%
250,782 $5.4 Million
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $83,011 - $125,027
4,863 Added 2.26%
219,950 $4.34 Million
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $89,745 - $123,631
4,395 Added 2.09%
215,087 $5.05 Million
Q4 2021

Feb 14, 2022

BUY
$25.89 - $33.45 $251,262 - $324,632
9,705 Added 4.83%
210,692 $5.74 Million
Q3 2021

Nov 15, 2021

SELL
$22.46 - $29.47 $1,145 - $1,502
-51 Reduced 0.03%
200,987 $5.54 Million
Q1 2021

May 17, 2021

SELL
$32.28 - $44.3 $7.49 Million - $10.3 Million
-231,972 Reduced 53.57%
201,038 $6.85 Million
Q4 2020

Feb 16, 2021

SELL
$31.45 - $40.54 $10.5 Million - $13.6 Million
-334,375 Reduced 43.57%
433,010 $14.4 Million
Q3 2020

Nov 16, 2020

SELL
$26.0 - $34.5 $3.36 Million - $4.46 Million
-129,405 Reduced 14.43%
767,385 $24.7 Million
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $10.7 Million - $22.4 Million
761,870 Added 564.68%
896,790 $24.7 Million
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $9,609 - $23,955
-705 Reduced 0.52%
134,920 $2.16 Million
Q4 2019

Feb 14, 2020

BUY
$16.12 - $24.98 $2.19 Million - $3.39 Million
135,625 New
135,625 $3.24 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.5B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.